US Patent Issued to ADVANCED ACCELERATOR APPLICATIONS (ITALY), The Johns Hopkins University on Nov. 3 for "Prostate specific membrane antigen (PSMA) ligands and uses thereof" (Italian, American Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,055, issued on Nov. 3, was assigned to ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL (Pozzilli, Italy) and The Johns Hopkins University (Baltimore).

"Prostate specific membrane antigen (PSMA) ligands and uses thereof" was invented by Maurizio F. Mariani (Ivrea, Italy), Lorenza Fugazza (Ivrea, Italy), Daniela Chicco (Pozzilli, Italy), Martin Gilbert Pomper (Baltimore) and Sangeeta Ray (Ellicott City, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to prostate specific membrane antigen (PSMA) ligands. In particular, the disclosure relates to PSMA ligands having a glutamate-urea-lysine (GUL) moiety and a chelating agent...